Maron R - Search Results

1

Oral tolerance to insulin and the insulin B-chain: cell lines and cytokine patterns.

Maron R, Blogg NS, Polanski M, Hancock W, Weiner HL. Maron R, et al. Ann N Y Acad Sci. 1996 Feb 13;778:346-57. doi: 10.1111/j.1749-6632.1996.tb21142.x. Ann N Y Acad Sci. 1996. PMID: 8610988 No abstract available.

2

Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines.

Weiner HL, Gonnella PA, Slavin A, Maron R. Weiner HL, et al. Among authors: maron r. Res Immunol. 1997 Oct-Dec;148(8-9):528-33. doi: 10.1016/s0923-2494(98)80146-6. Res Immunol. 1997. PMID: 9588831 Review. No abstract available.

3

Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.

Frenkel D, Huang Z, Maron R, Koldzic DN, Hancock WW, Moskowitz MA, Weiner HL. Frenkel D, et al. Among authors: maron r. J Immunol. 2003 Dec 15;171(12):6549-55. doi: 10.4049/jimmunol.171.12.6549. J Immunol. 2003. PMID: 14662856

4

Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.

Ishikawa H, Ochi H, Chen ML, Frenkel D, Maron R, Weiner HL. Ishikawa H, et al. Among authors: maron r. Diabetes. 2007 Aug;56(8):2103-9. doi: 10.2337/db06-1632. Epub 2007 Apr 24. Diabetes. 2007. PMID: 17456848

5

Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice.

Ilan Y, Maron R, Tukpah AM, Maioli TU, Murugaiyan G, Yang K, Wu HY, Weiner HL. Ilan Y, et al. Among authors: maron r. Proc Natl Acad Sci U S A. 2010 May 25;107(21):9765-70. doi: 10.1073/pnas.0908771107. Epub 2010 May 5. Proc Natl Acad Sci U S A. 2010. PMID: 20445103 Free PMC article.

6

Oral administration of schistosome egg antigens and insulin B-chain generates and enhances Th2-type responses in NOD mice.

Maron R, Palanivel V, Weiner HL, Harn DA. Maron R, et al. Clin Immunol Immunopathol. 1998 Apr;87(1):85-92. doi: 10.1006/clin.1997.4506. Clin Immunol Immunopathol. 1998. PMID: 9576014

7

Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.

Maron R, Melican NS, Weiner HL. Maron R, et al. J Autoimmun. 1999 Jun;12(4):251-8. doi: 10.1006/jaut.1999.0278. J Autoimmun. 1999. PMID: 10330296

8

Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.

Garcia G, Komagata Y, Slavin AJ, Maron R, Weiner HL. Garcia G, et al. Among authors: maron r. J Autoimmun. 1999 Nov;13(3):315-24. doi: 10.1006/jaut.1999.0320. J Autoimmun. 1999. PMID: 10550219

9

Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.

Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ. Weiner HL, et al. Among authors: maron r. Ann Neurol. 2000 Oct;48(4):567-79. Ann Neurol. 2000. PMID: 11026440

10

Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice.

Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Desai R, Hancock WW, Weiner HL, Selkoe DJ. Lemere CA, et al. Among authors: maron r. Ann N Y Acad Sci. 2000;920:328-31. doi: 10.1111/j.1749-6632.2000.tb06943.x. Ann N Y Acad Sci. 2000. PMID: 11193172 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters